Mutation Testing in Melanoma Families
Author Information
Author(s): Newton Bishop J A, Harland M, Bennett D C, Bataille V, Goldstein A M, Tucker M A, Ponder B A J, Cuzick J, Selby P, Bishop D T
Primary Institution: ICRF Genetic Epidemiology, Leeds, UK
Hypothesis
The study investigates the role of INK4A and CDK4 gene mutations in familial melanoma susceptibility.
Conclusion
The study found INK4A mutations in 9 families but no CDK4 mutations, suggesting that INK4A is a significant factor in melanoma susceptibility.
Supporting Evidence
- Nine families were identified with INK4A mutations.
- No CDK4 exon 2 mutations were found in the studied families.
- INK4A mutations were found in 35% of families with three or more melanoma cases.
Takeaway
The researchers looked at families with melanoma to see if certain genes were causing it, and they found one gene that was linked to the disease in some families.
Methodology
Mutation screening of the INK4A and CDK4 genes was performed in 42 UK families.
Limitations
The study did not identify mutations in the CDK4 gene and only focused on specific genes.
Participant Demographics
The study involved 42 UK families with a history of melanoma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website